Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model

Virology

Volumn 360, Issue 2, 2007, Pages 454-460

  Julander, Justin G ^a   Siddharthan, Venkatraman ^a   Blatt, Lawrence M ^b   Schafer, Kristiina ^a   Sidwell, Robert W ^a   Morrey, John D ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b InterMune Inc   (United States)

Author keywords

Alphavirus; Ampligen ; Antiviral; Hamster; Infergen; Interferon; Mode; Treatment; Western equine encephalitis virus

Indexed keywords

AMPLIGEN; CONSENSUS INTERFERON; INTERFERON; INTERFERON INDUCING AGENT; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENCEPHALOMYELITIS; HAMSTER; INOCULATION; KIDNEY; LIVER; MESENCEPHALON; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; SURVIVAL; WEIGHT GAIN; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ANIMALS; ANTIVIRAL AGENTS; BODY WEIGHT; BRAIN; CEREBRAL CORTEX; CRICETINAE; DISEASE MODELS, ANIMAL; ENCEPHALITIS VIRUS, WESTERN EQUINE; ENCEPHALOMYELITIS, EQUINE; INTERFERON INDUCERS; INTERFERON TYPE I, RECOMBINANT; KIDNEY; LIVER; MESENCEPHALON; MESOCRICETUS; POLY I-C; POLY U; SERUM;

ALPHAVIRUS; CRICETINAE; MUS; WESTERN EQUINE ENCEPHALOMYELITIS VIRUS;

EID: 33947580584     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.10.031     Document Type: Article

References (41)

1. Aguilar M.J. Pathological changes in brain and other target organs of infant and weanling mice after infection with non-neuroadapted western equine encephalitis virus. Infect. Immun. 2 (1970) 533-542
2. Anon. Mismatched double-stranded RNA: polyI:polyC12U. Drugs R & D 5 (2004) 297-304
3. Balan V., Nelson D.R., Sulkowski M.S., Everson G.T., Lambiase L.R., Wiesner R.H., Dickson R.C., Post A.B., Redfield R.R., Davis G.L., Neumann A.U., Osborn B.L., Freimuth W.W., and Subramanian G.M. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy. Antivir. Ther. 11 (2006) 35-45
4. Bianchi T.I., Aviles G., Monath T.P., and Sabattini M.S. Western equine encephalomyelitis: virulence markers and their epidemiologic significance. Am. J. Trop. Med. Hyg. 49 (1993) 322-328
5. Calisher C.H. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7 (1994) 89-116
6. Dremov D.P., Solyanik R.G., Miryutova T.L., and Laptakova L.M. Attenuated variants of eastern equine encephalomyelitis virus: pathomorphological, immunofluorescence and virological studies of infection in Syrian hamsters. Acta Virol. 22 (1978) 139-145
7. Essey R.J., McDougall B.R., and Robinson Jr. W.E. Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro. Antiviral Res. 51 (2001) 189-202
8. Garen P.D., Tsai T.F., and Powers J.M. Human eastern equine encephalitis: immunohistochemistry and ultrastructure. Mod. Pathol. 12 (1999) 646-652
9. Georges-Courbot M.C., Contamin H., Faure C., Loth P., Baize S., Leyssen P., Neyts J., and Deubel V. Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob. Agents Chemother. 50 (2006) 1768-1772
10. Gowen B.B., Barnard D.L., Smee D.F., Wong M.H., Pace A.M., Jung K.H., Winslow S.G., Bailey K.W., Blatt L.M., and Sidwell R.W. Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob. Agents Chemother. 49 (2005) 2378-2386
11. Hardy J.L., Presser S.B., Chiles R.E., and Reeves W.C. Mouse and baby chicken virulence of enzootic strains of western equine encephalomyelitis virus from California. Am. J. Trop. Med. Hyg. 57 (1997) 240-244
12. Hayles L.B. Susceptibility of the Mongolian gerbil (Meriones unguiculatus) to Western equine encephalitis. Can. J. Microbiol. 18 (1972) 941-944
13. Hisaka T., Yano H., Ogasawara S., Momosaki S., Nishida N., Takemoto Y., Kojiro S., Katafuchi Y., and Kojiro M. Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo. J. Hepatol. 41 (2004) 782-789
14. Hunt A.R., and Roehrig J.T. Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology 142 (1985) 334-346
15. Jahrling P.B. Virulence heterogeneity of a predominantly avirulent Western equine encephalitis virus population. J. Gen. Virol. 32 (1976) 121-128
16. Jahrling P.B., Hesse R.A., Anderson A.O., and Gangemi J.D. Opsonization of alphaviruses in hamsters. J. Med. Virol. 12 (1983) 1-16
17. Kim J.H., Booss J., Manuelidis E.E., and Duncan C.C. Human eastern equine encephalitis. Electron microscopic study of a brain biopsy. Am. J. Clin. Pathol. 84 (1985) 223-227
18. Leyssen P., Drosten C., Paning M., Charlier N., Paeshuyse J., De Clercq E., and Neyts J. Interferons, interferon inducers, and interferon-ribavirin in treatment of flavivirus-induced encephalitis in mice. Antimicrob. Agents Chemother. 47 (2003) 777-782
19. Liu T., and Chambers T.J. Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes. J. Virol. 75 (2001) 2107-2118
20. Liu C., Voth D.W., Rodina P., Shauf L.R., and Gonzalez G. A comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations. J. Infect. Dis. 122 (1970) 53-63
21. Melian E.B., and Plosker G.L. Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C. Drugs 61 (2001) 1661-1691
22. Monath T.P., Kemp G.E., Cropp C.B., and Chandler F.W. Necrotizing myocarditis in mice infected with Western equine encephalitis virus: clinical, electrocardiographic, and histopathologic correlations. J. Infect. Dis. 138 (1978) 59-66
23. Morrey J.D., Day C.W., Julander J.G., Blatt L.M., Smee D.F., and Sidwell R.W. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chem. Chemother. 15 (2004) 67-75
24. Morrey J.D., Day C.W., Julander J.G., Olsen A.L., Sidwell R.W., Cheney C.D., and Blatt L.M. Modeling hamsters for evaluating West Nile virus therapies. Antiviral Res. 63 (2004) 41-50
25. Morrey, J.D., Siddharthan, V., Olsen, A.L., Roper, G.Y., Wang, H.C., Baldwin, T.J., Koenig, S., Johnson, S., Nordstrom, J.L. and Diamond, M.S., (in press). Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters. J. of Infect. Dis. (accepted).
26. Nagata L.P., Hu W.G., Masri S.A., Rayner G.A., Schmaltz F.L., Das D., Wu J., Long M.C., Chan C., Proll D., Jager S., Jebailey L., Suresh M.R., and Wong J.P. Efficacy of DNA vaccination against western equine encephalitis virus infection. Vaccine 23 (2005) 2280-2283
27. Nagata L.P., Hu W.G., Parker M., Chau D., Rayner G.A., Schmaltz F.L., and Wong J.P. Infectivity variation and genetic diversity among strains of Western equine encephalitis virus. J. Gen. Virol. 87 (2006) 2353-2361
28. Reed D.S., Larsen T., Sullivan L.J., Lind C.M., Lackemeyer M.G., Pratt W.D., and Parker M.D. Aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques. J. Infect. Dis. 192 (2005) 1173-1182
29. Schoneboom B.A., Fultz M.J., Miller T.H., McKinney L.C., and Grieder F.B. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. NeuroVirol. 5 (1999) 342-354
30. Shrestha B., Gottlieb D., and Diamond M.S. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 77 (2003) 13203-13213
31. Sidwell R.W., and Smee D.F. Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res. 57 (2003) 101-111
32. Sjogren M.H., Sjogren R., Holtzmuller K., Winston B., Butterfield B., Drake S., Watts A., Howard R., and Smith M. Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C. Dig. Dis. Sci. 50 (2005) 727-732
33. Smee D.F., Gilbert J., Leonhardt J.A., Barnett B.B., Huggins J.H., and Sidwell R.W. Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen®. Antivir. Res. 20 (1993) 57-70
34. Takehara M. Antiviral effects of double-stranded RNA from rice dwarf virus on infection of mice with western equine encephalitis virus. Microbiol. Immunol. 21 (1977) 309-315
35. Takemoto Y., Yano H., Momosaki S., Ogasawara S., Nishida N., Kojiro S., Kamura T., and Kojiro M. Antiproliferative effects of interferon-alphaCon1 on ovarian clear cell adenocarcinoma in vitro and in vivo. Clin. Cancer Res. 10 (2004) 7418-7426
36. Tesh R.B., Guzman H., da Rosa A.P., Vasconcelos P.F., Dias L.B., Bunnell J.E., Zhang H., and Xiao S.Y. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus): I. Virologic, biochemical, and immunologic studies. J. Infect. Dis. 183 (2001) 1431-1436
37. Wild J.S., Hyde D.M., Hubbell H.R., and Giri S.N. Dose-related effects of Ampligen® (poly(I).poly(C12U)), a mismatched double-stranded RNA, in a bleomycin-mouse model of pulmonary fibrosis. Exp. Lung Res. 22 (1996) 375-391
38. Wong J.P., Nagata L.P., Christopher M.E., Salazar A.M., and Dale R.M. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs. Vaccine 23 (2005) 2266-2268
39. Yasuda S., and Miyata K. Interferon alfacon-1 (Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile. Nippon Yakurigaku Zasshi 120 (2002) 421-426
40. Yasuda S., Huffman J.H., Smee D.F., Sidwell R.W., and Miyata K. Spectrum of virus inhibition by consensus interferon YM643. Antiviral Chem. Chemother. 11 (2000) 337-341
41. Zlotnick I., Peacock S., Grant D.P., and Batter-Hatton D. The pathogenesis of western equine encephalitis virus (W.E.E.) in adult hamsters with special reference to the long and short term effects on the C.N.S. of the attenuated clone 15 variant. Br. J. Exp. Pathol. 53 (1972) 59-77